Latest Insights on DNA

Interstellar Inflation wait for Wall Street worrying here meme small Last Call For Inflation Fears; You, Me & Genetic Privacy
by Joseph Hargett July 13, 2021 Great Stuff
The Last, Last Word On Inflation (For Real This Time) Sup, Great Ones! How are you lot today? Everything all right at home? In your portfolios? Anything you want to get off your chest and into our inbox for Reader Feedback? Just checking in on y’all before we dive into the meat of the matter […]
Weird science Intellia therapeutics biotech meme small Intellia-gent Investing, Tesla’s Not-A-Recall & Binance Schminance
by Joseph Hargett June 28, 2021 Great Stuff
Wall Street’s Weird Science ♫ From my heart and from my hand, why don’t people understand … my intentions? ♫ Great Ones, did you see what happened in the biotech market today? Holy cow … it was poetry in motion. Intellia Therapeutics (Nasdaq: ) skyrocketed more than 50% after early trial data showed the company’s […]
Should invest in 23andMe depends on info give me meme small Genes Get Wilder: 23andMe, You & Big Brother
by Joseph Hargett June 19, 2021 Great Stuff
What’s The Deal With 23andMe? Great Ones, what do you know about 23andMe (Nasdaq: )? Some of you probably know 23andMe from its home testing kits. No, not home drug tests — genetic tests that tell you where your ancestors came from. 23andMe’s tests were a popular holiday/birthday gift a few years ago. According to […]
Semiconductor wars Nvidia AMD Intel dragons meme small Nvidia ARM Wrestles U.K., AMD Scores With Google & Trade Desk Decimated
by Joseph Hargett June 18, 2021 Great Stuff
Friday Four Play: The “AnARMchy In The U.K.” Edition Great Ones, have you checked in on your Nvidia (Nasdaq: ) position lately? What Nvidia position? You know, the one I recommended not three weeks ago in Great Stuff’s weekend edition: “What’s The Deal With Nvidia?” I made it an official Great Stuff Picks recommendation too. […]
Revolutionary technology set to disrupt biotech industry New Biotech SPACs Could Help Spark a Rally One venture capitalist’s decision to specifically target biotech companies suggests the industry presents the highest return potential.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“Loving the 238% gain after I bought your recommendation in Sept. 2019! This week (July 21, 2020) will be my 1 year anniversary with your amazing team … thanks for the life-changing work you all do! Between all your services, 14 triple-digit gains, the greatest at 358%!"

- Matt

“Thirteen of my positions are up well over 50% in less than a year since joining your service. Two are in the triple digits with several close behind. My personal money manager, who works for one of the largest banks in the country, is envious of my gains. I never dreamed this was possible. My trips to China to teach English to young Chinese students is now much more affordable. Thank you for your dedication and help.”

- Chris K.

“Looks like I have finally found the right person to learn and grow from.”

- James

Share This